TheWealthWeb

Bajaj Finserv Healthcare Fund Direct Growth

Bajaj Finserv Mutual FundEquity Scheme - Sectoral/ ThematicDirect · GrowthRisk: Very High

NAV ₹12.491 on 13 November 2026

AMFI name: BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH · Scheme code 153157 · ISIN INF0QA701AB9

1 year
+24.09%
Since launch, a year
+12.15%
NAV performance, last year

Returns

To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.

PeriodThis fundNIFTY HEALTHCARE INDEX TRICategory median
1M+9.38%+8.67%+5.71%
6M+17.41%+12.84%+7.79%
1Y+24.09%+38.92%+4.11%
3Y-+28.05%+14.35%
5Y--+12.25%

Benchmark: NIFTY HEALTHCARE INDEX TRI (total return index), measured over the same dates. The scheme document names BSE Healthcare Total Return Index (TRI), which we do not hold, so this is the closest NSE index.

Category median: the middle return among Direct plans (Growth option) in AMFI's “Equity Scheme - Sectoral/ Thematic” category, up to 174 funds with clean data. Ranks are under “Rank among peers”.

Risk

From daily NAVs. Alpha, beta and capture are measured against NIFTY HEALTHCARE INDEX TRI.

Volatility
13.56%
Annualised, 1 year
Max drawdown
-15.68%
Worst fall from a peak, 3 years
Sharpe ratio
1.33
Return above the risk-free rate per unit of volatility, 1 year
Sortino ratio
0.69
Like Sharpe, counting only falls, 3 years
Alpha
+0.56%
Return a year beyond what beta explains, 3 years
Beta
0.44
1.00 moves in step with the benchmark, 3 years
Upside capture
59%
Share of the benchmark's rises captured, 3 years
Downside capture
90%
Share of the benchmark's falls taken (lower is better), 3 years

Rank among peers

Direct plans, Growth option, in AMFI's “Equity Scheme - Sectoral/ Thematic” category. Each rank counts only the peers that have that figure.

Compare with Top Peers
3-Year Return Rank
-of 142
-
N/A
Q1
Q2
Q3
Q4
1-Year Return RankQ1
#10of 233
+24.09%
Ahead of 223 of the other 232
Q1
Q2
Q3
Q4
Sharpe (Risk-Adjusted)Q1
#6of 233
1.33
Ahead of 227 of the other 232
Q1
Q2
Q3
Q4
Highest 3-year returns in the categoryDirect plans · Growth option
RankScheme Name3Y Return1Y ReturnSharpeDirect TERAUM
#1
Nippon India Mutual Fund
+46.52%+60.64%1.071.06%₹1,100 Cr
#2
HDFC Mutual Fund
+33.64%+20.34%1.070.89%₹11,128 Cr
#3
HDFC Mutual Fund
+31.28%+31.60%1.761.03%₹3,128 Cr
#4
SBI Mutual Fund
+25.42%+26.07%1.470.76%₹5,565 Cr
#5
HDFC Mutual Fund
+24.77%+10.10%1.091.10%₹1,997 Cr
#6
Mirae Asset Mutual Fund
+24.42%+27.89%1.28-₹3,458 Cr
#7
UTI Mutual Fund
+23.89%+22.00%1.311.35%₹1,399 Cr
#8
ICICI Prudential Mutual Fund
+22.73%+10.29%0.952.08%₹3,926 Cr
#-
Bajaj Finserv Healthcare FundCurrent Fund
Bajaj Finserv Mutual Fund
-+24.09%1.330.90%₹389 Cr

Costs and fund facts

Expense ratio (stated maximum)
Direct 0.90% · Regular 2.59%
Exit load
Entry load – Nil Exit load – For each purchase of units through Lumpsum / switch-in / Systematic Investment Plan (SIP) and Systematic Transfer Plan (STP), exit load will be as follows: • if units are redeemed / switched out within 3 months from the date of allotment: 1% of applicable NAV. • if units are redeemed/switched out after 3 months from the date of allotment, no exit load is payable. The Scheme will not levy exit load in case the timelines for rebalancing portfolio as stated in SEBI Master Circular for Mutual Funds dated June 27, 2024, is not complied with. The Trustee / AMC reserves the right to change the load structure any time in the future if they so deem fit on a prospective basis. The investor is requested to check the prevailing load structure of the scheme before investing.
Fund size (all plans)
₹389 CrAverage, quarter to September 2026
Benchmark
BSE Healthcare Total Return Index (TRI)Compared here with NIFTY HEALTHCARE INDEX TRI
Allotment date
27 December 2024Scheme document
Type
An open ended equity scheme investing in pharma, healthcare and allied theme
AMFI scheme code
153157

Fund managers (4)

  • Bharat Hegde (Equity Portion)
  • Sorbh Gupta
  • (Equity Portion)
  • FM-3- Mr. Siddharth Chaudhary (Debt Portion)

How each manager has done since taking over: fund manager scorecard.

Investment objective

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.

From the scheme summary document filed with AMFI.

SIP calculator

A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.

Monthly SIP Amount₹10,000
Investment Horizon5 Years
Simulating monthly 1st from 30 Dec 2024 to 13 Nov 2026
Total Invested24 mos
₹2,40,000
Units: 23,938.398
Current Portfolio Value
₹2,99,015
At latest recorded NAV
Total Profit
+₹59,015
+24.6% absolute return
SIP XIRR
24.00%
Annualised, money-weighted
Wealth CompositionProfit is 25% of total invested capital
Invested: ₹2,40,000Profit Generated: ₹59,015
Same SIP in the benchmark (NIFTY HEALTHCARE INDEX TRI)Same dates & amounts
Scheme SIP Valuation
₹2,99,015
24.0% XIRR
Benchmark SIP Valuation
₹5,56,767
25.8% XIRR
Fund minus benchmark
₹-2,57,752
Over 24 monthly installments
SIP instalments are bought on the first NAV date of each month; values use the latest NAV we hold. Past returns are not a guide to future returns.

About this fund

Bajaj Finserv Healthcare Fund Direct Growth is a mutual fund scheme from Bajaj Finserv Mutual Fund, listed by AMFI under “Equity Scheme - Sectoral/ Thematic”. This page covers the Direct plan with the Growth option. Its NAV was ₹12.491 on 13 November 2026. It returned 24.09% over 1 year, measured from NAVs (3- and 5-year figures are annualised). Its benchmark, NIFTY HEALTHCARE INDEX TRI, returned 38.92% over 1 year. Q-Score: 73 out of 100, rated only against funds in the same category. The fund house rates its risk as “Very High” on the SEBI riskometer. Its average assets under management were ₹389 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 0.90% a year for the Direct plan. Managed by Bharat Hegde (Equity Portion), Sorbh Gupta, (Equity Portion) and FM-3- Mr. Siddharth Chaudhary (Debt Portion). Its scheme summary document gives the allotment date as 27 December 2024.

Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.

Plans and options of this fund (4)

PlanOptionISINAMFI codeNAV
DirectThis pageGrowthINF0QA701AB9153157₹12.4913 Nov 2026
DirectIDCWINF0QA701AC7153156₹12.4913 Nov 2026
RegularGrowthINF0QA701987153155₹12.1013 Nov 2026
RegularIDCWINF0QA701995153158₹12.1013 Nov 2026